Abstract
In order to implement community case management of malaria strategy in a rural area of intense transmission, of children using artemether-lumefantrine combination, we assessed the therapeutic efficacy of the medicine. We conducted an open label and uncontrolled clinical trial in an unique centre from September 2009 to December 2009 in children 6-59 months old who consulted at health facilities for uncomplicated malaria. The primary endpoint was clinical and parasitological cure rate at day 28 corrected by PCR. In total 106 children were enrolled. Parasite clearance at day 2 was 99.04% and the adequate clinical and parasitological response corrected by PCR at day 28 was 90.5%. Our results confirm that artemether-lumefantrine combination is still effective.
MeSH terms
-
Age of Onset
-
Antimalarials / administration & dosage
-
Antimalarials / adverse effects
-
Antimalarials / therapeutic use
-
Artemether, Lumefantrine Drug Combination
-
Artemisinins / adverse effects
-
Artemisinins / therapeutic use*
-
Burkina Faso
-
Child, Preschool
-
Drug Combinations
-
Ethanolamines / adverse effects
-
Ethanolamines / therapeutic use*
-
Female
-
Fever / drug therapy
-
Fever / epidemiology
-
Fever / etiology
-
Fluorenes / adverse effects
-
Fluorenes / therapeutic use*
-
Humans
-
Infant
-
Malaria, Falciparum / blood
-
Malaria, Falciparum / complications
-
Malaria, Falciparum / drug therapy*
-
Malaria, Falciparum / epidemiology
-
Male
-
Parasitemia / diagnosis
-
Parasitemia / drug therapy
-
Rural Population
-
Treatment Outcome
Substances
-
Antimalarials
-
Artemether, Lumefantrine Drug Combination
-
Artemisinins
-
Drug Combinations
-
Ethanolamines
-
Fluorenes